Mario Herrero, a professor in the Department of Global Development and a Cornell Atkinson Scholar, has been appointed to the EAT-Lancet 2.0 leadership team to spearhead the modeling workstream.
The lack of alcohol in nonalcoholic or low-alcohol beer – particularly during manufacturing, storage and pouring – may prompt conditions ripe for foodborne pathogen growth.
Fei-Fei Li, co-director of Stanford’s Human-Centered AI Institute, will discuss AI’s role in improving patient safety in health care in the annual Cornell Center for Social Sciences Distinguished Lecture in the Social Sciences, on Oct. 5 in Statler Auditorium.
Structural insights into a potent antimalarial drug candidate’s interaction with a malaria parasite have paved the way for drug-resistant malaria therapies, according to a new study by researchers at Weill Cornell Medicine and Van Andel Institute.
The financial stability of providers and their ability to serve patients is being threatened by Wall Street, according to new research co-authored by ILR Professor Rose Batt.
Patients who have drug-resistant tuberculosis have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine.
Researchers from Weill Cornell Medicine have provided the first national estimate of caregivers’ pain and arthritis experiences that can limit their ability to perform necessary tasks while caring for older family members.
A new study – using lab mice genetically modified with a human gene to shed light on a potential link between arsenic exposure and diabetes – revealed that while the male mice exposed to arsenic in drinking water developed diabetes, the female mice did not.
In this episode of the Inclusive Excellence Podcast, Erin Sember-Chase and Toral Patel invite C Lucas, wellness community programming specialist at Cornell, for a conversation about the challenges and complexities that exist in the fitness industry.